111 related articles for article (PubMed ID: 38157982)
21. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
22. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
[TBL] [Abstract][Full Text] [Related]
23. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
24. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
26. A competing risk nomogram for predicting cancer-specific death of patients with buccal mucosa cancer.
Jiang Q; Xue D; Xin Y; Qiu J
Oral Dis; 2021 May; 27(4):900-910. PubMed ID: 32791562
[TBL] [Abstract][Full Text] [Related]
27. Competing risk nomogram for predicting prognosis of patients with spinal and pelvic chordoma: A SEER-based retrospective study.
Li J; Ma C; Yuan X; Li N; Xu Y; Guo J; Liao H
Eur Spine J; 2023 Apr; 32(4):1334-1344. PubMed ID: 36805321
[TBL] [Abstract][Full Text] [Related]
28. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
[TBL] [Abstract][Full Text] [Related]
29. Competing-risks model for predicting the prognosis of penile cancer based on the SEER database.
Yang J; Pan Z; He Y; Zhao F; Feng X; Liu Q; Lyu J
Cancer Med; 2019 Dec; 8(18):7881-7889. PubMed ID: 31657120
[TBL] [Abstract][Full Text] [Related]
30. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
31. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
32. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
[TBL] [Abstract][Full Text] [Related]
33. Competing risk models versus traditional Cox models for prognostic factors' prediction and care recommendation in patients with advanced laryngeal squamous carcinoma: a population-based study.
Song Z; Chen Z; Sun X; Zou L
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3745-3756. PubMed ID: 37115325
[TBL] [Abstract][Full Text] [Related]
34. Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.
Su H; Wang S; Xie S; Huang L; Pan Y; Lyu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10435-10452. PubMed ID: 37278827
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors among single primary gliosarcoma cases: A study using Surveillance, Epidemiology, and End Results data from 1973-2013.
Chen B; Liu B; Wu C; Wang Z
Cancer Med; 2019 Oct; 8(14):6233-6242. PubMed ID: 31464103
[TBL] [Abstract][Full Text] [Related]
36. Competing risk nomogram for predicting cancer-specific mortality in patients with non-melanoma skin cancer.
Tang L; Zhang L; Zeng Y; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8817-8827. PubMed ID: 37142808
[TBL] [Abstract][Full Text] [Related]
37. Application of competing risk model in the prognostic prediction study of patients with follicular thyroid carcinoma.
Wang Z; Mo C; Chen L; Kong L; Wu K; Zhu Y; Chen X
Updates Surg; 2022 Apr; 74(2):735-746. PubMed ID: 34086182
[TBL] [Abstract][Full Text] [Related]
38. Prognostic nomogram for colorectal cancer patients with multi-organ metastases: a Surveillance, Epidemiology, and End Results program database analysis.
Tang X; Hu N; Huang S; Jiang J; Rao H; Yang X; Yuan Y; Zhang Y; Xia G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12131-12143. PubMed ID: 37428251
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.
Luo W; Chen H; Wang J; Qiu J; Zhang T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12393-12404. PubMed ID: 37438539
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
